There are 2867 resources available
Dissecting response to treatment in adult patients with a glioma
Presenter: Roel Verhaak
Session: Hard-to-treat cancers: What makes them special?
Resources:
Slides
Webcast
Modelling and targeting MRD in melanoma
Presenter: Rebecca Lee
Session: Detection, characterisation and targeting of minimal residual disease
Resources:
Slides
Webcast
Advances in HER2-targeted therapy or novel targeted therapies for HER2
Presenter: Kohei Shitara
Session: Evolving targets and treatment options in oesophagogastric cancer
Resources:
Slides
Webcast
ctDNA in bladder and kidney cancers
Presenter: Lars Dyrskjot
Session: Multidisciplinary updates in biomarkers in urinary cancers
Resources:
Slides
Webcast
Threading the needle: Considerations for immunotherapy in special populations
Presenter: Martin Reck
Session: The current and future of immunotherapy for metastatic NSCLC
Resources:
Slides
Webcast
Tumor agnostics in thyroid cancer: RET
Presenter: Jaume Capdevila Castillon
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Pivotal new phase III trials in the first-line setting: Incorporating IO into management
Presenter: Darren Wan-Teck Lim
Session: New developments in the management of recurrent/metastatic nasopharyngeal cancer
Resources:
Slides
Webcast
Invited Discussant 786O and 788O
Presenter: Sapna Patel
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Slides
Webcast
Invited Discussant LBA24 and 315O
Presenter: Maria Elena Elez Fernandez
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Slides
Webcast
Cancer centres and networks: New ways of delivery care during and after the pandemic
Presenter: Rosa Giuliani
Session: In collaboration with the WHO: The impact of COVID-19 on cancer services globally: Challenges and lessons learned
Resources:
Slides
Webcast